PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $403,146 | -42.2% | 84,517 | +5.5% | 0.00% | -50.0% |
| Q4 2022 | $697,122 | -67.1% | 80,129 | -55.0% | 0.00% | -66.7% |
| Q3 2022 | $2,119,000 | +217.7% | 178,078 | +280.3% | 0.01% | +200.0% |
| Q2 2022 | $667,000 | -56.7% | 46,824 | -29.8% | 0.00% | -73.3% |
| Q4 2021 | $1,542,000 | +30.1% | 66,743 | +67.9% | 0.02% | 0.0% |
| Q3 2021 | $1,185,000 | +199.2% | 39,751 | +242.7% | 0.02% | +275.0% |
| Q2 2021 | $396,000 | – | 11,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |